Wednesday, April 17, 2019

Swiss drugmaker Roche raised its 2019 outlook after first-quarter sales rose 8 percent, beating analyst estimates on the strength of newer medicines including multiple sclerosis treatment Ocrevus and cancer immunotherapy Tecentriq.


from Reuters: Business News https://reut.rs/2KIXu1H

Related Posts:

  • LATEST BUSINESS NEWSThe government is considering restricting alcohol sales at airports in England and Wales in the early morning. We went to one airport pub to get patrons’ reaction. from NYT > Business Day https://ift.tt/2SFIMZh … Read More
  • LATEST BUSINESS NEWSMorningstar said that explaining the plans more clearly could help persuade more parents to use them. The lower fees might also help. from NYT > Business Day https://ift.tt/2Jyu0zz … Read More
  • LATEST BUSINESS NEWSGoogle employees marched to protest workplace harassment. Apple profits soared. But the big news was social media’s role in real-world violence. from NYT > Business Day https://ift.tt/2PAVjP0 … Read More
  • LATEST BUSINESS NEWSThe activist investor is likely to benefit from the food maker whether his ambitious plans gain traction or not. from NYT > Business Day https://ift.tt/2zqNRf5 … Read More
  • LATEST BUSINESS NEWSWhere is this growth really coming from; how real is the concern over inflation; and how many more workers are out there? from NYT > Business Day https://ift.tt/2OlUhSu … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner